Vi anbefaler at du alltid bruker siste versjon av nettleseren din.

Publikasjoner

Her vil det bli lagt ut nye artikler som har blitt publisert med tilknytning SESAM forskningsmiljø. Oversikt over alle artikler publisert før 2023 ligger som PDF filer under publikasjonslister 2012–2023.

SESAM har hittil i 2024 hatt 77 publikasjoner i ulike tidsskrifter.​

 

  1. Altomare, D., Libri, I., Alberici, A., Rivolta, J., Padovani, A., Ashton, N. J., Zetterberg, H., Blennow, K., & Borroni, B. (2024). Plasma biomarkers increase diagnostic confidence in patients with Alzheimer's disease or frontotemporal lobar degeneration. Alzheimer's Research & Therapy, 16(1), 107. https://doi.org/10.1186/s13195-024-01236-7. PMID: 38734612.  
     
  2. Arctaedius, I., Levin, H., Thorgeirsdóttir, B., Moseby-Knappe, M., Cronberg, T., Annborn, M., Nielsen, N., Zetterberg, H., Blennow, K., Ashton, N. J., Frigyesi, A., Friberg, H., Lybeck, A., & Mattsson-Carlgren, N. (2024). Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest. Critical Care, 28(1), 116. https://doi.org/10.1186/s13054-024-04670-8. PMID: 38594704.
     
  3. Arslan, B., Zetterberg, H., & Ashton, N. J. (2024). Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics. Clinical Chemistry and Laboratory Medicine, 62(6), 1063–1069. https://doi.org/10.1515/cclm-2023-0750. PMID: 38253262.
      
  4. Ashton, N. J., Brum, W. S., Di Molfetta, G., Benedet, A. L., Arslan, B., Jonaitis, E., Langhough, R. E., Cody, K., Wilson, R., Carlsson, C. M., Vanmechelen, E., Montoliu-Gaya, L., Lantero-Rodriguez, J., Rahmouni, N., Tissot, C., Stevenson, J., Servaes, S., Therriault, J., Pascoal, T., Lleó, A., ... Zetterberg, H. (2024). Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurology, 81(3), 255–263. https://doi.org/10.1001/jamaneurol.2023.0753. PMID: 38252443.  

  5. Ashton, N. J., Di Molfetta, G., Tan, K., Blennow, K., Zetterberg, H., & Messing, A. (2024). Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease. Neurological Sciences, 45(9), 4513–4518. https://doi.org/10.1007/s10072-023-06692-0.  
    PMID: 38558318.  

  6. Ashton, N. J., Keshavan, A., Brum, W. S., Andreasson, U., Arslan, B., Droescher, M., Barghorn, S., Vanbrabant, J., Lambrechts, C., Van Loo, M., Stoops, E., Iyengar, S., Ji, H., Xu, X., Forrest-Hay, A., Zhang, B., Luo, Y., Jeromin, A., Vandijck, M., Bastard, N. L., ... Zetterberg, H. (2024). The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau round robin study. medRxiv. https://doi.org/10.1101/2024.08.22.24312244. PMID: 39228740.
     
  7. Baril, A. A., Picard, C., Labonté, A., Sanchez, E., Duclos, C., Mohammediyan, B., Ashton, N. J., Zetterberg, H., Blennow, K., Breitner, J. C. S., Villeneuve, S., Poirier, J., & PREVENT‐AD Research Group. (2024). Day-to-day sleep variability with Alzheimer's biomarkers in at-risk elderly. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 16(1), e12521. https://doi.org/10.1002/alz.12521. PMID: 38371359.   

  8. Bastgen, T., Evers, J., Oedekoven, C., Weide, C., Herzog, L., Ashton, N. J., Zetterberg, H., Blennow, K., Albus, A., Vidovic, N., Kraff, O., Deuschl, C., & Dodel, R. (2024). Repetitive head injuries in German American football players do not change blood-based biomarker candidates for CTE during a single season. Neurological Research and Practice, 6(1), 13. https://doi.org/10.1186/s42466-024-00126-w. PMID: 38419110.  

  9. Beckers, E., Van Egroo, M., Ashton, N. J., Blennow, K., Vandewalle, G., Zetterberg, H., Poser, B. A., & Jacobs, H. I. L. (2024). Microstructural associations between locus coeruleus, cortical, and subcortical regions are modulated by astrocyte reactivity: A 7T MRI adult lifespan study. Cerebral Cortex, 34(6), bhae261. https://doi.org/10.1093/cercor/bhac038. PMID: 3890408.
     
  10. Bolsewig, K., van Unnik, A. A. J. M., Blujdea, E. R., Gonzalez, M. C., Ashton, N. J., Aarsland, D., Zetterberg, H., Padovani, A., Bonanni, L., Mollenhauer, B., Schade, S., Vandenberghe, R., Poesen, K., Kramberger, M. G., Paquet, C., Bousiges, O., Cretin, B., Willemse, E. A. J., Teunissen, C. E., & Lemstra, A. W. (2024). Association of plasma amyloid, P-tau, GFAP, and NfL with CSF, clinical, and cognitive features in patients with dementia with Lewy bodies. Neurology, 102(12), e209418. https://doi.org/10.1212/WNL.00000000000209418. PMID: 38830138.   

  11. Borda, M. G., Duque, G., Pérez-Zepeda, M. U., Baldera, J. P., Westman, E., Zettergren, A., Samuelsson, J., Kern, S., Rydén, L., Skoog, I., & Aarsland, D. (2024). Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia. Journal of Cachexia, Sarcopenia and Muscle, 15(1), 189–197. https://doi.org/10.1002/jcsm.13128. PMID: 38050325.  

  12. Borda, M. G., Baldera, J. P., Samuelsson, J., Zettergren, A., Rydén, L., Westman, E., Pérez-Zepeda, M. U., Kern, S., Venegas, L. C., Duque, G., Skoog, I., & Aarsland, D. (2024). Temporal muscle thickness: A practical approximation for assessing muscle mass in older adults. Journal of the American Medical Directors Association, 25(4), 664–670.e3. https://doi.org/10.1016/j.jamda.2023.12.025. PMID: 38307124.  

  13. Borda, M. G., Salazar-Londoño, S., Lafuente-Sanchis, P., Baldera, J. P., Venegas, L. C., Tarazona-Santabalbina, F. J., Aarsland, D., Martín-Marco, A., & Pérez-Zepeda, M. U. (2024). Neutrophil-to-lymphocyte ratio and lymphocyte count as an alternative to body mass index for screening malnutrition in older adults living in the community. European Journal of Nutrition, 63(5), 1889–1899. https://doi.org/10.1007/s00394-024-03392-0. PMID: 38613694.  

  14. Borda, M. G., Lafuente-Sanchis, P., Baldera, J. P., Tarazona-Santabalbina, F. J., Chavarro-Carvajal, D. A., Salazar-Londoño, S., Bocharova, M., Aarsland, D., & Martín-Marco, A. (2024). Assessing neutrophil-to-lymphocyte ratio as a nutritional indicator in community-dwelling older adults. Archives of Medical Research, 55(4), 103003. https://doi.org/10.1016/j.arcmed.2024.103003. PMID: 38795422.  

  15. Borda, M. G., Barreto, G. E., Baldera, J. P., de Lucia, C., Khalifa, K., Bergland, A. K., Pola, I., Botero-Rodríguez, F., Siow, R. C., Kivipelto, M., Zetterberg, H., Ashton, N. J., Ballard, C., & Aarsland, D.; NJ FINGER. (2024). A randomized, placebo-controlled trial of purified anthocyanins on cognitive function in individuals at elevated risk for dementia: Analysis of inflammatory biomarkers toward personalized interventions. Experimental Gerontology, 196, 112569. https://doi.org/10.1016/j.exger.2024.112569. PMID:v39226946. 

  16. Brum, W. S., Ashton, N. J., Simrén, J., di Molfetta, G., Karikari, T. K., Benedet, A. L., Zimmer, E. R., Lantero-Rodriguez, J., Montoliu-Gaya, L., Jeromin, A., Aarsand, A. K., Bartlett, W. A., Calle, P. F., Coşkun, A., Díaz-Garzón, J., Jonker, N., Zetterberg, H., Sandberg, S., Carobene, A., & Blennow, K. (2024). Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals. Alzheimer's & Dementia, 20(2), 1284–1297. https://doi.org/10.1002/alz.13518. PMID: 38109077. 

  17. Brum, W. S., Docherty, K. F., Ashton, N. J., Zetterberg, H., Hansson, O., McMurray, J. J. V., & Blennow, K. (2024). Effect of neprilysin inhibition on Alzheimer disease plasma biomarkers: A secondary analysis of a randomized clinical trial. JAMA Neurology, 81(2), 197–200. https://doi.org/10.1001/jamaneurol.2023.4719. PMID: 38486040. 

  18. Brum, W. S., Cullen, N. C., Therriault, J., Janelidze, S., Rahmouni, N., Stevenson, J., Servaes, S., Benedet, A. L., Zimmer, E. R., Stomrud, E., Palmqvist, S., Zetterberg, H., Frisoni, G. B., Ashton, N. J., Blennow, K., Mattsson-Carlgren, N., Rosa-Neto, P., & Hansson, O. (2024). A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings. Nature Communications, 15(1), 2311. https://doi.org/10.1038/s41467-024-46603-2. PMID: 39366843. 

  19. Carmona-Iragui, M., O'Connor, A., Llibre-Guerra, J., Lao, P., Ashton, N. J., Fortea, J., & Sánchez-Valle, R. (2024). Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome. EBioMedicine, 108, 105327. https://doi.org/10.1016/j.ebiom.2024.105327. PMID: 39366843 

  20. Castellanos-Perilla, N., Borda, M. G., Aarsland, D., & Barreto, G. E. (2024). An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention. Expert Review of Neurotherapeutics, 24(3), 313–324. https://doi.org/10.1080/14737175.2024.2313547. PMID: 38379273 

  21. Chong, J. R., de Lucia, C., Tovar-Rios, D. A., Castellanos-Perilla, N., Collins, C., Kvernberg, S. M., Ballard, C., Siow, R. C., & Aarsland, D. (2024). A randomised, double-blind, placebo-controlled, cross-over clinical trial to evaluate the biological effects and safety of a polyphenol supplement on healthy ageing. Antioxidants, 13(8), 995. https://doi.org/10.3390/antiox13080995. PMID: 39199240 

  22. Coley, N., Zetterberg, H., Cantet, C., Guyonnet, S., Ashton, N. J., Vellas, B., Blennow, K., & Andrieu, S.; MAPT study group. (2024). Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: A secondary analysis of a randomised, controlled, dementia prevention trial. The Lancet Healthy Longevity, 5(2), e120–e130. https://doi.org/10.1016/S2666-7568(23)00255-6. PMID: 38310892 

  23. Dai, X., Liu, S., Li, X., Chen, K., Gao, S., Wang, J., Aarsland, D., Han, Z. R., & Zhang, Z. (2024). Longitudinal association between depressive symptoms and cognitive function: The neurological mechanism of psychological and physical disturbances on memory. Psychological Medicine. Advance online publication. https://doi.org/10.1017/S0033291724001612. PMID: 39397683 

  24. Dodel, R., Berg, D., Dunsing, T., Kalbe, E., Meyer, P. T., Ramirez, A., Storch, A., Aarsland, D., & Jessen, F. (2024). Demenz mit Lewy-Körpern: alte und neue Erkenntnisse – Teil 2: Behandlung [Dementia with Lewy bodies: old and new knowledge - Part 2: Treatment]. Der Nervenarzt, 95(4), 362–367. https://doi.org/10.1007/s00115-023-01577-2. PMID: 38095659 

  25. Duggan, M. R., Gomez, G. T., Joynes, C. M., Bilgel, M., Chen, J., Fattorelli, N., Hohman, T. J., Mancuso, R., Cordon, J., Castellano, T., Koran, M. E. I., Candia, J., Lewis, A., Moghekar, A., Ashton, N. J., Kac, P. R., Karikari, T. K., Blennow, K., Zetterberg, H., ... Walker, K. A. (2024). Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression. Brain, Behavior, and Immunity, 120, 604–619. https://doi.org/10.1016/j.bbi.2024.07.002. PMID: 38977137. 

  26. Erdemli, G., Grammatikopoulou, M., Wagner, B., Vairavan, S., Curcic, J., Aarsland, D., Wittenberg, G., Nikolopoulos, S., Muurling, M., Froehlich, H., de Boer, C., Shanbhag, N. M., Nies, V. J. M., Coello, N., Gove, D., Diaz, A., Foy, S., Dartee, W., & Brem, A. K. (2024). Regulatory considerations for developing remote measurement technologies for Alzheimer's disease research. NPJ Digital Medicine, 7(1), 232. https://doi.org/10.1038/s41746-024-01211-8. PMID: 39232033 

  27. Eriksson, C. M., Kirsebom, B. E., Espenes, R., Siafarikas, N., Waterloo, K., Rongve, A., Selnes, P., Aarsland, D., Fladby, T., & Hessen, E. (2024). Depressive symptoms are not associated with predementia cerebrospinal fluid amyloid pathology. Dementia and Geriatric Cognitive Disorders Extra, 14(1), 40–48. https://doi.org/10.1159/000539284. PMID: 38939101 

  28. Ferrari-Souza, J. P., Brum, W. S., Hauschild, L. A., Da Ros, L. U., Ferreira, P. C. L., Bellaver, B., Leffa, D. T., Bieger, A., Tissot, C., Lussier, F. Z., De Bastiani, M. A., Povala, G., Benedet, A. L., Therriault, J., Wang, Y. T., Ashton, N. J., Zetterberg, H., Blennow, K., ... Zimmer, E. R. (2024). Vascular risk burden is a key player in the early progression of Alzheimer's disease. Neurobiology of Aging, 136, 88–98. https://doi.org/10.1016/j.neurobiolaging.2023.12.008. PMID: 38335912 

  29. Frisoni, G. B., Festari, C., Massa, F., Cotta Ramusino, M., Orini, S., Aarsland, D., Agosta, F., Babiloni, C., Borroni, B., Cappa, S. F., Frederiksen, K. S., Froelich, L., Garibotto, V., Haliassos, A., Jessen, F., Kamondi, A., Kessels, R. P., Morbelli, S. D., O'Brien, J. T., ... Nobili, F. (2024). European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. The Lancet Neurology, 23(3), 302–312. https://doi.org/10.1016/S1474-4422(23)00447-7. PMID: 38365381. 

  30. García-Tercero, E., Belenguer-Varea, Á., Villalon-Ruibio, D., López Gómez, J., Trigo-Suarez, R., Cunha-Pérez, C., Borda, M. G., & Tarazona-Santabalbina, F. J. (2024). Respiratory complications are the main predictors of 1-year mortality in patients with hip fractures: The results from the Alzira retrospective cohort study. Geriatrics, 9(2), 47. https://doi.org/10.3390/geriatrics9020047. PMID: 38667514 

  31. Gibson, L. L., Weintraub, D., Lemmen, R., Perera, G., Chaudhuri, K. R., Svenningsson, P., & Aarsland, D. (2024). Risk of dementia in Parkinson's disease: A systematic review and meta-analysis. Movement Disorders, 39(10), 1697–1709. https://doi.org/10.1002/mds.29918, PMID: 39036849
     
  32. Gibson, L. L., Mueller, C., Stewart, R., & Aarsland, D. (2024). Characteristics associated with progression to probable dementia with Lewy bodies in a cohort with very late-onset psychosis. Psychological Medicine, 54(12), 1–10. https://doi.org/10.1017/S0033291724001922. PMID: 39324394 

  33. Gonzalez-Ortiz, F., Kirsebom, B. E., Contador, J., Tanley, J. E., Selnes, P., Gísladóttir, B., Pålhaugen, L., Suhr Hemminghyth, M., Jarholm, J., Skogseth, R., Bråthen, G., Grøndtvedt, G., Bjørnerud, A., Tecelao, S., Waterloo, K., Aarsland, D., Fernández-Lebrero, A., García-Escobar, G., Navalpotro-Gómez, I., ... Blennow, K. (2024). Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease. Nature Communications, 15(1), 2908. https://doi.org/10.1038/s41467-024-47286-5. PMID: 38575616 

  34. Gurholt, T. P., Borda, M. G., Parker, N., Fominykh, V., Kjelkenes, R., Linge, J., van der Meer, D., Sønderby, I. E., Duque, G., Westlye, L. T., Aarsland, D., & Andreassen, O. A. (2024). Linking sarcopenia, brain structure and cognitive performance: A large-scale UK Biobank study. Brain Communications, 6(2), fcae083. https://doi.org/10.1093/braincomms/fcae083. PMID: 38510210 

  35. Guu, T. W., Brem, A. K., Albertyn, C. P., Kandangwa, P., Aarsland, D., & Ffytche, D. (2024). Wrist-worn actigraphy in agitated late-stage dementia patients: A feasibility study on digital inclusion. Alzheimer's & Dementia, 20(5), 3211–3218. https://doi.org/10.1002/alz.13772. PMID: 38497216 

  36. Habich, A., Oltra, J., Schwarz, C. G., Przybelski, S. A., Oppedal, K., Inguanzo, A., Blanc, F., Lemstra, A. W., Hort, J., Westman, E., Segura, B., Junque, C., Lowe, V. J., Boeve, B. F., Aarsland, D., Dierks, T., Kantarci, K., & Ferreira, D. (2024). Grey matter networks in women and men with dementia with Lewy bodies. NPJ Parkinson’s Disease, 10(1), 84. https://doi.org/10.1038/s41531-024-00702-5. PMID: 38615089 

  37. Haniff, Z. R., Bocharova, M., Mantingh, T., Rucker, J. J., Velayudhan, L., Taylor, D. M., Young, A. H., Aarsland, D., Vernon, A. C., & Thuret, S. (2024). Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases. Pharmacology & Therapeutics, 258, 108641. https://doi.org/10.1016/j.pharmthera.2024.108641. PMID: 38583670 

  38. Huber, H., Blennow, K., Zetterberg, H., Boada, M., Jeromin, A., Weninger, H., Nuñez-Llaves, R., Aguilera, N., Ramis, M., Simrén, J., Nilsson, J., Lantero-Rodriguez, J., Orellana, A., García-Gutiérrez, F., Morató, X., Ashton, N. J., & Montoliu-Gaya, L. (2024). Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots: A new collection method for remote settings. Alzheimer’s & Dementia, 20(4), 2340–2352. https://doi.org/10.1002/alz.13697. PMID: 38284555 

  39. Jaramillo-Jimenez, A., Tovar-Rios, D. A., Mantilla-Ramos, Y. J., Ochoa-Gomez, J. F., Bonanni, L., & Brønnick, K. (2024). ComBat models for harmonization of resting-state EEG features in multisite studies. Clinical Neurophysiology, 167, 241–253. https://doi.org/10.1016/j.clinph.2024.09.019. PMID: 39369552 

  40. Kac, P. R., González-Ortiz, F., Emeršič, A., Dulewicz, M., Koutarapu, S., Turton, M., An, Y., Smirnov, D., Kulczyńska-Przybik, A., Varma, V. R., Ashton, N. J., Montoliu-Gaya, L., Camporesi, E., Winkel, I., Paradowski, B., Moghekar, A., Troncoso, J. C., Lashley, T., Brinkmalm, G., ... Blennow, K. (2024). Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology. Nature Communications, 15(1), 2615. https://doi.org/10.1038/s41467-024-46876-7. PMID: 38521766 

  41. Kajander, M., Gjestsen, M. T., Ballard, C., Næss, H., & Testad, I. (2024). Health promotion in early-stage dementia: A focused ethnographic study of a 12-week group-based educational intervention. SAGE Open Nursing, 10, 23779608241266686. https://doi.org/10.1177/23779608241266686. PMID: 39070007 

  42. Koivumäki, M., Ekblad, L., Lantero-Rodriguez, J., Ashton, N. J., Karikari, T. K., Helin, S., Parkkola, R., Lötjönen, J., Zetterberg, H., Blennow, K., Rinne, J. O., & Snellman, A. (2024). Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly. Alzheimer's Research & Therapy, 16(1), 112. https://doi.org/10.1186/s13195-024-01477-w. . PMID: 38762725 

  43. Kolanko, M. A., Huber, H., David, M. C. B., Montoliu-Gaya, L., Simrén, J., Blennow, K., Zetterberg, H., Nilforooshan, R., Malhotra, P., Sharp, D. J., Ashton, N. J., & Graham, N. S. N. (2024). Quantification of neurofilament light and glial fibrillary acidic protein in finger-prick blood. Brain Communications, 6(3), fcae151. https://doi.org/10.1093/braincomms/fcae151. PMID: 38903933 

  44. Lantero-Rodriguez, J., Camporesi, E., Montoliu-Gaya, L., Gobom, J., Piotrowska, D., Olsson, M., Burmann, I. M., Becker, B., Brinkmalm, A., Burmann, B. M., Perkinton, M., Ashton, N. J., Fox, N. C., Lashley, T., Zetterberg, H., Blennow, K., & Brinkmalm, G. (2024). Tau protein profiling in tauopathies: A human brain study. Molecular Neurodegeneration, 19(1), 54. https://doi.org/10.1186/s13024-024-00741-9. PMID: 39026372 

  45. Lennon, M. J., Rigney, G., Creese, B., Aarsland, D., Hampshire, A., Ballard, C., Corbett, A., & Raymont, V. (2024). Sports-related concussion not associated with long-term cognitive or behavioural deficits: The PROTECT-TBI study. Journal of Neurology, Neurosurgery & Psychiatry. Advance online publication. https://doi.org/10.1136/jnnp-2024-334039. PMID: 39231581 

  46. Londoño Pereira, M., Estrada Restrepo, A., Preciado Tamayo, Á. M., Botero Bernal, M., & Germán Borda, M. (2024). Associations between nutritional status and abdominal adiposity with cognitive domains and depressive symptoms in older persons with multimorbidity: Understanding an understudied population. Revista Española de Geriatría y Gerontología, 60(1), 101558. https://doi.org/10.1016/j.regg.2024.101558, PMID: 39369640 

  47. Martínez-Dubarbie, F., López-García, S., Lage, C., Di Molfetta, G., Fernández-Matarrubia, M., Pozueta-Cantudo, A., García-Martínez, M., Corrales-Pardo, A., Bravo, M., Jiménez-Bonilla, J., Quirce, R., Marco de Lucas, E., Drake-Pérez, M., Tordesillas, D., López-Hoyos, M., Irure-Ventura, J., Valeriano-Lorenzo, E., Blennow, K., Ashton, N. J., ... Sánchez-Juan, P. (2024). Plasma phosphorylated tau 231 increases at one-year intervals in cognitively unimpaired subjects. Journal of Alzheimer’s Disease, 98(3), 1029–1042. https://doi.org/10.3233/JAD-231479. PMID: 38489191 

  48. Mattsson-Carlgren, N., Collij, L. E., Stomrud, E., Pichet Binette, A., Ossenkoppele, R., Smith, R., Karlsson, L., Lantero-Rodriguez, J., Snellman, A., Strandberg, O., Palmqvist, S., Ashton, N. J., Blennow, K., Janelidze, S., & Hansson, O. (2024). Plasma biomarker strategy for selecting patients with Alzheimer disease for antiamyloid immunotherapies. JAMA Neurology, 81(1), 69–78. https://doi.org/10.1001/jamaneurol.2023.4596. PMID: 38048096 

  49. Mendes, A. J., Ribaldi, F., Lathuiliere, A., Ashton, N. J., Janelidze, S., Zetterberg, H., Scheffler, M., Assal, F., Garibotto, V., Blennow, K., Hansson, O., & Frisoni, G. B. (2024). Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort. Journal of Neurology, 271(4), 2053–2066. https://doi.org/10.1007/s00415-023-12148-5. PMID: 38195896 

  50. Mendes AJ, Ribaldi F, Lathuiliere A, Ashton NJ, Zetterberg H, Abramowicz M, Scheffler M, Assal F, Garibotto V, Blennow K, Frisoni GB. (2024). Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients. Alzheimers Res Ther. 2024;16(1):110. https://doi:10.1186/s13195-024-01478-9. PMID: 38755703 

  51. Muurling, M., de Boer, C., Hinds, C., Atreya, A., Doherty, A., Alepopoulos, V., Curcic, J., Brem, A. K., Conde, P., Kuruppu, S., Morató, X., Saletti, V., Galluzzi, S., Vilarino Luis, E., Cardoso, S., Stukelj, T., Kramberger, M. G., Roik, D., Koychev, I., ... RADAR-AD consortium. (2024). Feasibility and usability of remote monitoring in Alzheimer’s disease. Digital Health, 10, 20552076241238133. https://doi.org/10.1177/20552076241238133. PMID: 38601188 

  52. Nilsson, J., Pichet Binette, A., Palmqvist, S., Brum, W. S., Janelidze, S., Ashton, N. J., Spotorno, N., Stomrud, E., Gobom, J., Zetterberg, H., Brinkmalm, A., Blennow, K., & Hansson, O. (2024). Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases. Brain, 147(7), 2414–2427. https://doi.org/10.1093/brain/awae032. PMID: 38325331 

  53. O’Brien, W. T., Spitz, G., Xie, B., Major, B. P., Mutimer, S., Giesler, L. P., Bain, J., Evans, L. J., Duarte Martins, B., Piantella, S., Alhassan, A., Brady, S., Cappellari, D., Somma, V., McColl, T., Symons, G. F., Gore, T., Sun, M., Kuek, T., ... McDonald, S. J. (2024). Biomarkers of neurobiologic recovery in adults with sport-related concussion. JAMA Network Open, 7(6), e2415983. https://doi.org/10.1001/jamanetworkopen.2024.15983. PMID: 38848061 

  54. Oltra, J., Habich, A., Schwarz, C. G., Nedelska, Z., Przybelski, S. A., Inguanzo, A., Diaz-Galvan, P., Lowe, V. J., Oppedal, K., Gonzalez, M. C., Philippi, N., Blanc, F., Barkhof, F., Lemstra, A. W., Hort, J., Padovani, A., Rektorova, I., Bonanni, L., Massa, F., ... Ferreira, D. (2024). Sex differences in brain atrophy in dementia with Lewy bodies. Alzheimer’s & Dementia, 20(3), 1815–1826. https://doi.org/10.1002/alz.13571. PMID: 38131463 

  55. Orduña Dolado, A., Stomrud, E., Ashton, N. J., Nilsson, J., Quijano-Rubio, C., Jethwa, A., Brum, W. S., Brinkmalm Westman, A., Zetterberg, H., Blennow, K., Janelidze, S., & Hansson, O. (2024). Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’s disease biomarkers. Alzheimer’s Research & Therapy, 16(1), 132. https://doi.org/10.1186/s13195-024-01503-x. PMID: 38909218 

  56. Peretti, D. E., Boccalini, C., Ribaldi, F., Scheffler, M., Marizzoni, M., Ashton, N. J., Zetterberg, H., Blennow, K., & Frisoni, G. B. (2024). Association of glial fibrillary acid protein, Alzheimer’s disease pathology, and cognitive decline. Brain. https://doi.org/10.1093/brain/awae211. PMID: 38940331 

  57. Pisani, S., Gosse, L., Aarsland, D., Ray Chaudhuri, K., Ballard, C., Ffytche, D., Velayudhan, L., & Bhattacharyya, S. (2024). Parkinson’s disease psychosis associated with accelerated multidomain cognitive decline. BMJ Mental Health, 27(1), 1–10. https://doi.org/10.1136/bmjment-2024-301062. PMID: 39043465

  58. Quaresima, V., Pilotto, A., Trasciatti, C., Tolassi, C., Parigi, M., Bertoli, D., Mordenti, C., Galli, A., Rizzardi, A., Caratozzolo, S., Benussi, A., Ashton, N. J., Blennow, K., Zetterberg, H., Giliani, S., Brugnoni, D., & Padovani, A. (2024). Plasma p-tau181 and amyloid markers in Alzheimer’s disease: A comparison between Lumipulse and SIMOA. Neurobiology of Aging, 143, 30–40. https://doi.org/10.1016/j.neurobiolaging.2024.08.007. PMID: 39208716 

  59. Reho, P., Saez-Atienzar, S., Ruffo, P., Solaiman, S., Shah, Z., Chia, R., Kaivola, K., Traynor, B. J., Tilley, B. S., Gentleman, S. M., Hodges, A. K., Aarsland, D., Monuki, E. S., Newell, K. L., Woltjer, R., Albert, M. S., Dawson, T. M., Rosenthal, L. S., Troncoso, J. C., ... Scholz, S. W. (2024). Differential methylation analysis in neuropathologically confirmed dementia with Lewy bodies. Communications Biology, 7(1), 35. https://doi.org/10.1038/s42003-023-05725-x. PMID: 38182665 

  60. Rennie, A., Ekman, U., Shams, S., Rydén, L., Samuelsson, J., Zettergren, A., Kern, S., Oppedal, K., Blanc, F., Hort, J., Garcia-Ptacek, S., Antonini, A., Lemstra, A. W., Padovani, A., Kramberger, M. G., Rektorová, I., Walker, Z., Snædal, J., Pardini, M., ... Ferreira, D. (2024). Cerebrovascular and Alzheimer’s disease biomarkers in dementia with Lewy bodies and other dementias. Brain Communications, 6(5), fcae290. https://doi.org/10.1093/braincomms/fcae290. PMID: 39291165

  61. Ribaldi, F., Palomo, R., Altomare, D., Scheffler, M., Assal, F., Ashton, N. J., Zetterberg, H., Blennow, K., Abramowicz, M., Garibotto, V., Chicherio, C., & Frisoni, G. B. (2024). The taxonomy of subjective cognitive decline: Proposal and first clinical evidence from the Geneva Memory Clinic cohort. Neurodegenerative Diseases, 24(1), 16–25. https://doi.org/10.1159/000539053. PMID: 38763140 

  62. Sanchez-Rodriguez, L. M., Bezgin, G., Carbonell, F., Therriault, J., Fernandez-Arias, J., Servaes, S., Rahmouni, N., Tissot, C., Stevenson, J., Karikari, T. K., Ashton, N. J., Benedet, A. L., Zetterberg, H., Blennow, K., Triana-Baltzer, G., Kolb, H. C., Rosa-Neto, P., & Iturria-Medina, Y. (2024). Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease. Communications Biology, 7(1), 528. https://doi.org/10.1038/s42003-024-06217-2. PMID: 38704445 

  63. Shi, Y., Dobkin, R., Weintraub, D., Cho, H. R., Caspell-Garcia, C., Bock, M., Brown, E., Aarsland, D., & Dahodwala, N. (2024). Association of baseline depression and anxiety with longitudinal health outcomes in Parkinson's disease. Movement Disorders Clinical Practice, 11(9), 1103–1112. https://doi.org/10.1002/mdc3.14145. PMID: 39367742 

  64. Slaaen, M., Røyset, I. M., Saltvedt, I., Grønberg, B. H., Halsteinli, V., Døhl, Ø., Vossius, C., Kirkevold, Ø., Bergh, S., Rostoft, S., Oldervoll, L., Bye, A., Melby, L., Røsstad, T., Eriksen, G. F., Sollid, M. I. V., Rolfson, D., & Šaltytė Benth, J. (2024). Geriatric assessment with management for older patients with cancer receiving radiotherapy: A cluster-randomised controlled pilot study. BMC Medicine, 22(1), 232. https://doi.org/10.1186/s12916-024-03446-4. PMID: 38853251 

  65. Stockbauer, A., Beyer, L., Huber, M., Kreuzer, A., Palleis, C., Katzdobler, S., Rauchmann, B. S., Morbelli, S., Chincarini, A., Bruffaerts, R., Vandenberghe, R., Kramberger, M. G., Trost, M., Garibotto, V., Nicastro, N., Lathuilière, A., Lemstra, A. W., van Berckel, B. N. M., Pilotto, A., ... Brendel, M. (2024). Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. European Journal of Nuclear Medicine and Molecular Imaging, 51(4), 1023–1034. https://doi.org/10.1007/s00259-023-06493-w. PMID: 37971501 

  66. Titlestad, I., Haugarvoll, K., Solvang, S. H., Norekvål, T. M., Skogseth, R. E., Andreassen, O. A., Årsland, D., Neerland, B. E., Nordrehaug, J. E., Tell, G. S., & Giil, L. M. (2024). Delirium is frequently underdiagnosed among older hospitalised patients despite available information in hospital medical records. Age and Ageing, 53(2), afae006. https://doi.org/10.1093/ageing/afae006. PMID: 38342753 

  67. Varma, V. R., An, Y., Kac, P. R., Bilgel, M., Moghekar, A., Loeffler, T., Amschl, D., Troncoso, J., Blennow, K., Zetterberg, H., Ashton, N. J., Resnick, S. M., & Thambisetty, M. (2024). Longitudinal progression of blood biomarkers reveals a key role of astrocyte reactivity in preclinical Alzheimer's disease. medRxiv. https://doi.org/10.1101/2024.01.25.24301779. PMID: 38343809 

  68. Vossius, C., Bergh, S., Selbæk, G., Lichtwarck, B., & Myhre, J. (2024). Cause and place of death in Norwegian nursing home residents. Scandinavian Journal of Public Health, 52(2), 159–165. https://doi.org/10.1177/14034948221140195. PMID: 36474362 

  69. Vrillon, A., Ashton, N. J., Karikari, T. K., Götze, K., Cognat, E., Dumurgier, J., Lilamand, M., Zetterberg, H., Blennow, K., & Paquet, C. (2024). Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: A memory clinic study. Journal of Neurology, 271(3), 1297–1310. https://doi.org/10.1007/s00415-023-12066-6. PMID: 37950758 

  70. Wang, H. L., Siow, R., Schmauck-Medina, T., Zhang, J., Sandset, P. M., Filshie, C., Lund, Ø., Partridge, L., Bergersen, L. H., Juel Rasmussen, L., Palikaras, K., Sotiropoulos, I., Storm-Mathisen, J., Rubinsztein, D. C., Spillantini, M. G., De Zeeuw, C. I., Watne, L. O., Vyhnalek, M., ... Fang, E. F. (2024). Meeting summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Dementia: Recent progress on the mechanisms and interventional strategies. Journal of Gerontology: Series A, 79(4), glae029. https://doi.org/10.1093/gerona/glae029. PMID: 38289789

  71. Wang, Y. T., Therriault, J., Servaes, S., Tissot, C., Rahmouni, N., Macedo, A. C., Fernandez-Arias, J., Mathotaarachchi, S. S., Benedet, A. L., Stevenson, J., Ashton, N. J., Lussier, F. Z., Pascoal, T. A., Zetterberg, H., Rajah, M. N., Blennow, K., Gauthier, S., & Rosa-Neto, P. (2024). Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females. Brain, 147(4), 1497–1510. https://doi.org/10.1093/brain/awad397. PMID: 37988283 

  72. Wang, Y. T., Ashton, N. J., Servaes, S., Nilsson, J., Woo, M. S., Pascoal, T. A., Tissot, C., Rahmouni, N., Therriault, J., Lussier, F., Chamoun, M., Gauthier, S., Brinkmalm, A., Zetterberg, H., Blennow, K., Rosa-Neto, P., & Benedet, A. L. (2024). The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer's disease. Translational Neurodegeneration, 13(1), 27. https://doi.org/10.1186/s40035-024-00420-1. PMID: 38802928 

  73. Wang, Y. T., Therriault, J., Tissot, C., Servaes, S., Rahmouni, N., Macedo, A. C., Fernandez-Arias, J., Mathotaarachchi, S. S., Stevenson, J., Lussier, F. Z., Benedet, A. L., Pascoal, T. A., Ashton, N. J., Zetterberg, H., Blennow, K., Gauthier, S., & Rosa-Neto, P. (2024). Hormone therapy is associated with lower Alzheimer's disease tau biomarkers in post-menopausal females: Evidence from two independent cohorts. Alzheimer’s Research & Therapy, 16(1), 162. https://doi.org/10.1186/s13195-024-01509-5. PMID: 39034389 

  74. Warmenhoven, N., Sánchez-Benavides, G., González-Escalante, A., Milà-Alomà, M., Shekari, M., López-Martos, D., Ortiz-Romero, P., Kollmorgen, G., Quijano-Rubio, C., Minguillón, C., Gispert, J. D., Vilor-Tejedor, N., Arenaza-Urquijo, E., Palpatzis, E., Ashton, N. J., Zetterberg, H., Blennow, K., Suárez-Calvet, M., & Grau-Rivera, O.; ALFA Study. (2024). CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease. Alzheimer’s & Dementia, 20(9), 5819–5832. https://doi.org/10.1002/alz.13862. PMID: 39032119 

  75. Wolff, A. W., Bidner, H., Remane, Y., Zimmer, J., Aarsland, D., Rascol, O., Wyse, R. K., Hapfelmeier, A., & Lingor, P. (2024). Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD). Frontiers in Aging Neuroscience, 16, 1308577. https://doi.org/10.3389/fnagi.2024.1308577. PMID: 38419648
     
  76. Wyman-Chick, K. A., Chaudhury, P., Bayram, E., Abdelnour, C., Matar, E., Chiu, S. Y., Ferreira, D., Hamilton, C. A., Donaghy, P. C., Rodriguez-Porcel, F., Toledo, J. B., Habich, A., Barrett, M. J., Patel, B., Jaramillo-Jimenez, A., Scott, G. D., & Kane, J. P. M. (2024). Differentiating prodromal dementia with Lewy bodies from prodromal Alzheimer's disease: A pragmatic review for clinicians. Neurology and Therapy, 13(3), 885–906. https://doi.org/10.1007/s40120-024-00620-x. PMID: 38720013 

  77. Yang, F., Smith, M. J., Siow, R. C. M., Aarsland, D., Maret, W., & Mann, G. E. (2024). Interactions between zinc and NRF2 in vascular redox signalling. Biochemical Society Transactions, 52(1), 269–278. https://doi.org/10.1042/BST20230490. PMID: 38372426 

 

Tidligere publikasjoner:

 

Vitenskapelige publikasjoner SESAM 2022.pdf

Vitenskapelige publikasjoner SESAM 2021.pdf

Vitenskapelige publikasjoner SESAM 2019.pdf

Vitenskapelige publikasjoner SESAM 2018.pdf

Vitenskapelige publikasjoner SESAM 2017.pdf

Vitenskapelige publikasjoner SESAM 2016.pdf

Vitenskapelige publikasjoner SESAM 2015.pdf

Vitenskapelige publikasjoner SESAM 2014.pdf

Vitenskapelige publikasjoner SESAM 2013.pdf

Vitenskapelige publikasjoner SESAM 2012.pdf

Sist oppdatert 12.01.2026